Original BioMedicals Co., Ltd. (TPEX:6483)

Original BioMedicals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	151.45	228.68	13.98	8.46	8.1
Short-Term Investments	89.74	99.8	34.93	74.85	-
Cash & Short-Term Investments	241.19	328.48	48.91	83.31	8.1
Cash Growth	-26.57%	571.60%	-41.29%	928.77%	-64.51%
Other Receivables	13.51	11.55	9.99	9.59	8.91
Receivables	13.51	11.55	9.99	9.59	8.91
Prepaid Expenses	-	-	-	-	0.71
Other Current Assets	1.61	1.37	0.89	1.55	0.09
Total Current Assets	256.31	341.4	59.79	94.46	17.8
Property, Plant & Equipment	21.9	28.08	36.19	41.03	47.72
Other Long-Term Assets	1.16	1.16	2.05	1.88	1.88
Total Assets	279.37	370.63	98.04	137.37	67.4
Accrued Expenses	6.76	7.48	4.29	3.93	2.31
Current Portion of Leases	4.52	4.26	3.62	3.14	2.95
Other Current Liabilities	3.15	18.12	2.46	1.44	1.29
Total Current Liabilities	14.43	29.86	10.36	8.52	6.55
Long-Term Leases	7.47	11.98	16.27	17.52	20.66
Other Long-Term Liabilities	2.23	2.23	2.23	2.23	2.23
Total Liabilities	24.12	44.07	28.86	28.26	29.44
Common Stock	659.92	655.5	470.5	470.5	287
Additional Paid-In Capital	384.17	384.9	252.85	252.51	330.99
Retained Earnings	-788.83	-713.84	-654.18	-613.9	-580.02
Shareholders' Equity	255.25	326.57	69.17	109.11	37.97
Total Liabilities & Equity	279.37	370.63	98.04	137.37	67.4
Total Debt	11.98	16.24	19.89	20.66	23.61
Net Cash (Debt)	229.21	312.24	29.02	62.65	-15.52
Net Cash Growth	-26.59%	976.08%	-53.69%	-	-
Net Cash Per Share	3.47	6.33	0.62	1.51	-0.56
Filing Date Shares Outstanding	65.99	65.55	47.05	47.05	28.7
Total Common Shares Outstanding	65.99	65.55	47.05	47.05	28.7
Working Capital	241.88	311.54	49.43	85.94	11.25
Book Value Per Share	3.87	4.98	1.47	2.32	1.32
Tangible Book Value	255.25	326.57	69.17	109.11	37.97
Tangible Book Value Per Share	3.87	4.98	1.47	2.32	1.32
Machinery	44.92	47.15	46.96	46.84	44.92
Leasehold Improvements	36.85	36.85	36.73	36.38	36.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.